General
Preferred name
LERCANIDIPINE
Synonyms
Lercanidipine hydrochloride hemihydrate ()
MASNIPIDINE ()
Corifeo ()
Carmen ()
Cardiovasc ()
LERCANIDIPINE HYDROCHLORIDE ()
Lercanidipine (hydrochloride) ()
Zanidip (hydrochloride), Masnidipine (hydrochloride) ()
Zanidip ()
REC-15/2375 ()
Lercanidipine hcl ()
Lercanil ()
Lercanidipino ()
P&D ID
PD009976
CAS
132866-11-6
100427-26-7
Tags
available
drug
drug candidate
Drug indication
Hypertension
Cardiovascular disease
Drug Status
approved
investigational
withdrawn
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Lercanidipine is a third-generation, lipophilic, brain-penetrant, vascular-selective and orally active dihydropyridine-calcium channel blocker with a pIC50 of 7.74 (converts from ¦ÌM). Lercanidipine has long lasting antihypertensive action as well as reno- and neuro-protective effect. Lercanidipine also shows anti-oxidant, anti-inflammatory and anti-apoptotic properties. Lercanidipine can be used in cardiovascular and neurological research[1][2][3][4][5].
DESCRIPTION Lercanidipine is a third-generation, lipophilic, brain-penetrant, vascular-selective and orally active dihydropyridine-calcium channel blocker with a pIC50 of 7.74 (converts from ¦ÌM). Lercanidipine has long lasting antihypertensive action as well as reno- and neuro-protective effect. Lercanidipine also shows anti-oxidant, anti-inflammatory and anti-apoptotic properties. Lercanidipine can be used in cardiovascular and neurological research[1][2][3][4][5].
PRICE 143
DESCRIPTION Lercanidipine (Masnidipine) is a calcium channel blocker of the dihydropyridine class.
DESCRIPTION L-type (Cav1.2b) vascular calcium channel antagonist (LOPAC library)
DESCRIPTION Lercanidipine hydrochloride (Corifeo) is a calcium channel blocker of the dihydropyridine class. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
6
Compound Sets
17
Cayman Chemical Bioactives
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
JUMP-Target 1 Compound Set
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
72
Properties
(calculated by RDKit )
Molecular Weight
611.3
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
1
Rotatable Bonds
12
Ring Count
4
Aromatic Ring Count
3
cLogP
6.48
TPSA
111.01
Fraction CSP3
0.33
Chiral centers
1.0
Largest ring
6.0
QED
0.14
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Cav1.2b
Target
Calcium Channel
CACNG1
p38 MAPK
Reactive Oxygen Species (ROS)
Reactive Oxygen Species
Therapeutic Class
Antihypertensive Agents
Pathway
Apoptosis
Immunology/Inflammation
MAPK/ERK Pathway
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Neuronal Signaling
NF-κB
Metabolism
NF-¦ÊB
Source data